Literature DB >> 19845621

Role of hypoxia-inducible factors in epigenetic regulation via histone demethylases.

Jun Yang1, Ioanna Ledaki, Helen Turley, Kevin C Gatter, Juan-Carlos Martinez Montero, Ji-Liang Li, Adrian L Harris.   

Abstract

Eukaryotic chromatin is subject to multiple posttranslational histone modifications such as acetylation, methylation, phosphorylation, and ubiquitination. These various covalent modifications have been proposed to constitute a "histone code," playing important roles in the establishment of global chromatin environments, transcription, DNA repair, and DNA replication. Among these modifications, histone methylation specifies regulatory marks that delineate transcriptionally active and inactive chromatin. These histone methyl marks were considered irreversible; however, recent identification of site-specific histone demethylases demonstrates that histone methylation is dynamically regulated, which may allow cells to rapidly change chromatin conformation to adapt to environmental stresses or intrinsic stimuli. Of major interest is the observation that these histone demethylase enzymes, which are in the Jumonji gene family, require oxygen to function and, in some cases, are induced by hypoxia in an HIFalpha-dependent manner. This provides a new mechanism for regulation of the response to hypoxia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19845621     DOI: 10.1111/j.1749-6632.2009.05027.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  43 in total

1.  Dynamic change of chromatin conformation in response to hypoxia enhances the expression of GLUT3 (SLC2A3) by cooperative interaction of hypoxia-inducible factor 1 and KDM3A.

Authors:  Imari Mimura; Masaomi Nangaku; Yasuharu Kanki; Shuichi Tsutsumi; Tsuyoshi Inoue; Takahide Kohro; Shogo Yamamoto; Takanori Fujita; Teppei Shimamura; Jun-ichi Suehiro; Akashi Taguchi; Mika Kobayashi; Kyoko Tanimura; Takeshi Inagaki; Toshiya Tanaka; Takao Hamakubo; Juro Sakai; Hiroyuki Aburatani; Tatsuhiko Kodama; Youichiro Wada
Journal:  Mol Cell Biol       Date:  2012-05-29       Impact factor: 4.272

Review 2.  The promise and failures of epigenetic therapies for cancer treatment.

Authors:  Pasano Bojang; Kenneth S Ramos
Journal:  Cancer Treat Rev       Date:  2013-07-05       Impact factor: 12.111

3.  Chromodomain Helicase DNA-Binding Protein 7 Is Suppressed in the Perinecrotic/Ischemic Microenvironment and Is a Novel Regulator of Glioblastoma Angiogenesis.

Authors:  Nathaniel H Boyd; Kiera Walker; Adetokunbo Ayokanmbi; Emily R Gordon; Julia Whetsel; Cynthia M Smith; Richard G Sanchez; Farah D Lubin; Asmi Chakraborty; Anh Nhat Tran; Cameron Herting; Dolores Hambardzumyan; G Yancey Gillespie; James R Hackney; Sara J Cooper; Kai Jiao; Anita B Hjelmeland
Journal:  Stem Cells       Date:  2019-01-24       Impact factor: 6.277

Review 4.  JARID1 Histone Demethylases: Emerging Targets in Cancer.

Authors:  Kayla M Harmeyer; Nicole D Facompre; Meenhard Herlyn; Devraj Basu
Journal:  Trends Cancer       Date:  2017-09-12

Review 5.  Molecular responses to hypoxia-inducible factor 1α and beyond.

Authors:  Jason Brocato; Yana Chervona; Max Costa
Journal:  Mol Pharmacol       Date:  2014-02-25       Impact factor: 4.436

Review 6.  Inhibitors of Protein Methyltransferases and Demethylases.

Authors:  H Ümit Kaniskan; Michael L Martini; Jian Jin
Journal:  Chem Rev       Date:  2017-03-24       Impact factor: 60.622

Review 7.  The role of histone demethylases in cancer therapy.

Authors:  Inga Hoffmann; Martin Roatsch; Martin L Schmitt; Luca Carlino; Martin Pippel; Wolfgang Sippl; Manfred Jung
Journal:  Mol Oncol       Date:  2012-08-07       Impact factor: 6.603

Review 8.  Significance of epigenetic landscape in cartilage regeneration from the cartilage development and pathology perspective.

Authors:  Jingting Li; James Ohliger; Ming Pei
Journal:  Stem Cells Dev       Date:  2014-04-01       Impact factor: 3.272

9.  Chronic cerebrovascular hypoperfusion affects global DNA methylation and histone acetylation in rat brain.

Authors:  Xiangmei Wu; Jing Sun; Liang Li
Journal:  Neurosci Bull       Date:  2013-05-28       Impact factor: 5.203

10.  Vitamin D Enhances the Efficacy of Irinotecan through miR-627-Mediated Inhibition of Intratumoral Drug Metabolism.

Authors:  Meiyan Sun; Qunshu Zhang; Xiaoyu Yang; Steven Y Qian; Bin Guo
Journal:  Mol Cancer Ther       Date:  2016-07-25       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.